1. Home
  2. KURA vs SBC Comparison

KURA vs SBC Comparison

Compare KURA & SBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • SBC
  • Stock Information
  • Founded
  • KURA 2014
  • SBC 2000
  • Country
  • KURA United States
  • SBC United States
  • Employees
  • KURA N/A
  • SBC N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SBC
  • Sector
  • KURA Health Care
  • SBC
  • Exchange
  • KURA Nasdaq
  • SBC NYSE
  • Market Cap
  • KURA 492.9M
  • SBC 476.6M
  • IPO Year
  • KURA N/A
  • SBC N/A
  • Fundamental
  • Price
  • KURA $5.85
  • SBC $4.31
  • Analyst Decision
  • KURA Strong Buy
  • SBC
  • Analyst Count
  • KURA 12
  • SBC 0
  • Target Price
  • KURA $24.50
  • SBC N/A
  • AVG Volume (30 Days)
  • KURA 1.3M
  • SBC 123.7K
  • Earning Date
  • KURA 08-07-2025
  • SBC 05-15-2025
  • Dividend Yield
  • KURA N/A
  • SBC N/A
  • EPS Growth
  • KURA N/A
  • SBC N/A
  • EPS
  • KURA N/A
  • SBC 0.50
  • Revenue
  • KURA $67,991,000.00
  • SBC $197,936,201.00
  • Revenue This Year
  • KURA $109.86
  • SBC N/A
  • Revenue Next Year
  • KURA $107.90
  • SBC $12.95
  • P/E Ratio
  • KURA N/A
  • SBC $8.63
  • Revenue Growth
  • KURA N/A
  • SBC N/A
  • 52 Week Low
  • KURA $5.41
  • SBC $2.62
  • 52 Week High
  • KURA $23.48
  • SBC $12.50
  • Technical
  • Relative Strength Index (RSI)
  • KURA 40.44
  • SBC N/A
  • Support Level
  • KURA $5.56
  • SBC N/A
  • Resistance Level
  • KURA $7.17
  • SBC N/A
  • Average True Range (ATR)
  • KURA 0.38
  • SBC 0.00
  • MACD
  • KURA -0.06
  • SBC 0.00
  • Stochastic Oscillator
  • KURA 6.05
  • SBC 0.00

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About SBC SBC MEDICAL GROUP HOLDINGS INCRPRTD

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). Company provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.

Share on Social Networks: